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Background: Anxiety and affective disorders can be disabling and have a major impact on the ability to work. In
Denmark, people with a mental disorder, and mainly non-psychotic disorders, represent a substantial and increasing
part of those receiving disability pensions. Previous studies have indicated that Individual Placement and Support
(IPS) has a positive effect on employment when provided to people with severe mental illness. This modified IPS
intervention is aimed at supporting people with recently diagnosed anxiety or affective disorders in regaining their
ability to work and facilitate their return to work or education.
Aim: To investigate whether an early modified IPS intervention has an effect on employment and education when
provided to people with recently diagnosed anxiety or affective disorders in a Danish context.
Methods/Design: The trial is a randomised, assessor-blinded, clinical superiority trial of an early modified IPS
intervention in addition to treatment-as-usual compared to treatment-as-usual alone for 324 participants diagnosed with
an affective disorder or anxiety disorder living in the Capital Region of Denmark. The primary outcome is competitive
employment or education at 24 months. Secondary outcomes are days of competitive employment or education, illness
symptoms and level of functioning including quality of life at follow-up 12 and 24 months after baseline.
Discussion: If the modified IPS intervention is shown to be superior to treatment-as-usual, a larger number of
disability pensions can probably be avoided and long-term sickness absences reduced, with major benefits to
society and patients. This trial will add to the evidence of how best to support people’s return to employment or
education after a psychiatric disorder.
Trial registration: NCT01721824
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Anxiety and affective disorders are often associated with
functional disability and can have a major impact on the
ability to work [1-4]. Through the 1990s, depression
alone was responsible for an annual loss of US$ 17 billion
due to work absenteeism and a total cost of US$ 43.7
billion (34.8 billion Euro) each year in direct and indirect* Correspondence: lone.hellstroem@regionh.dk
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reproduction in any medium, provided the orsocietal costs in the USA [4]. In Denmark, mental health
problems account for a total of 7.3 billion Euro each year in
direct and indirect societal costs [5]. Disability pension and
long-term sickness absence account for the majority [5,6].
A significant amount of the total sickness absence in
Denmark is due to mental illness, and disability pensions
are increasingly awarded due to non-psychotic mental ill-
ness [6,7]. Hence it is crucial to start initiatives to support
patients with mental health problems in retaining or regain-
ing their employment or education.ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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early intervention for people with mood and anxiety dis-
order (IPS-MA) is an individualised supported employment
intervention, aiming at supporting people with recently
diagnosed anxiety or affective disorders to obtain and sus-
tain competitive employment through mentor support. It
was created in 2011, based on the experience of a 1-year
pilot study, aspects from the supported employment inter-
vention IPS and findings from the literature. The method
has never been investigated in a clinical trial.
A recent systematic review of randomised trials as well
as controlled non-randomised cohort studies [8] found an
overall lack of evidence concerning vocational rehabilitation
for patients with recently diagnosed bipolar disorders,
depression or anxiety disorders, but points to three import-
ant initiatives to consider: preventive interventions,
return-to-work interventions and interventions concerning
short- or long-term loss of employment. Preventive in-
terventions have only been investigated for patients with
depression or depressive symptoms, and show evidence
in favour of individualised interventions [9-11]. Considering
return to work interventions, studies suggest that an indi-
vidual intervention should be combined with work-place
interventions in close collaboration with mental health
services [4,12,13]. Returning to work when diagnosed with
depression, anxiety or bipolar disorders is also affected by
personal and social factors; hence, it is important to
incorporate interventions supporting these matters.
Today, vocational rehabilitation mainly consists of two
different approaches: pre-vocational training, often re-
ferred to as the train-and-place model, and supported
employment, referred to as place-and-train [14]. With
pre-vocational training, people are trained in company
internship programmes, sheltered workshops or wage-
subsidised jobs before obtaining competitive employment.
Supported employment aims at a rapid search for competi-
tive employment, with on-going support after employment.
In Denmark pre-vocational training is still standard.
The most intensively studied supported employment
intervention is IPS [15,16], where job consultants are inte-
grated in and act in close collaboration with the mental
health services. Several randomised trials [14,17-27] have
indicated that IPS is more effective in helping patients
with severe mental illness obtain and sustain competi-
tive employment compared to traditional pre-vocational
training. A meta-analysis [28] of four randomised trials
[29-32] found that, after 18 months, 70.4% had obtained
competitive employment in the IPS group compared to
24.3% in the control group. In a review including 11 ran-
domised trials comparing IPS to traditional pre-vocational
training, 61% of the patients obtained competitive employ-
ment in the IPS group versus 23% in the control group
[15]. No studies were found investigating the effect of IPS
when provided to people with recently diagnosed affectiveor anxiety disorder. It is recommended that the interven-
tion be modified and accommodated to psychosocial and
medical aspects, and thoroughly investigated in order to
show an effect when offered to, for instance, patients with
recently diagnosed anxiety or affective disorders [16]. Fur-
ther studies are needed in order to investigate the effect of
such interventions, in addition to mental health treatment,
on people’s return to work.
Sherpa ran the pilot study, from October 2010 to
September 2011 (unpublished data), during which 46
patients with depression, anxiety or a bipolar disorder
were referred to Sherpa from two mental health centres in
Copenhagen. Two mentors and a career counsellor were
employed at the time. Twenty of the participating patients
had obtained either employment or education after a me-
dian of 4.2 months (range 1 to 8 months).
The above-mentioned findings from the literature,
aspects from the IPS, and the experiences from the 1-year
pilot study led to the creation of IPS-MA in 2011.
The IPS-MA is an individualised supported employment
intervention, considering personal and social factors, as
well as career counselling and financial guidance. Focus is
on a rapid search for competitive employment or edu-
cation, and not sheltered workshops or long internship
programmes. Since people with affective disorders or
anxiety are treated by either their general practitioner,
psychiatric private practitioner or in mental health
centres in Denmark, it is difficult to integrate IPS-MA
with treatment to the same extend as in IPS. According
to IPS-MA, mentors must have an assertive approach
to mental health carers and social workers, and collab-
orate with mental health services as well as job centres
and municipalities, and thereby help coordinate services
provided by these.
This is the first trial comparing the effect of IPS-MA to
treatment-as-usual when provided to people with recently
diagnosed anxiety or affective disorders. The hypothesis is
that more people receiving IPS-MA will return to work or
education compared to the control group.
Methods
Design
The Sherpa trial is a randomised, assessor-blinded, clin-
ical superiority trial comparing IPS-MA in addition to
treatment-as-usual with treatment-as-usual alone in 324
patients recently diagnosed with an affective disorder or
an anxiety disorder (Figure 1).
Participants
Participants will be recruited from Mental Health
Centres and private practising psychiatrists within the
Capital Region of Denmark from 1 October 2011 until
31 January 2014. Inpatients as well as outpatients are
eligible.
Figure 1 Flow chart for participants in the trial.
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Participants must be aged 18 to 60 years, diagnosed by
the referring psychiatrists according to the International
Classification of Diseases 10th edition criteria of affective
disorders (F30-39) or anxiety disorders (F40-41), and not
have had contact with mental health services for more
than 3 years. They must have been employed or enrolled
in education at some time during the past 2 years.
They must have a pronounced wish to return to either
employment or education, but not being ready to do so
within the following 3 months, and equal to ‘match
group’ 2 or 3. (‘Match groups’ are categories used by
the job centres in Denmark [33] to estimate how far
people are from the labour market. Match group 2 re-
fers to people who can participate in pre-vocational
training or courses, but who would not be able to take
an ordinary job and be off social benefits within 3
months. Match group 3 refers to people with problems
so severe that they cannot work or participate in pre-
vocational training). Participants must have the ability
to read and understand Danish, and give informed consent
verbally and in writing.
Exclusion criteria
Participants will be excluded if they have somatic co-
morbidity causing reduced ability to work, primary
large-scale alcohol or substance abuse, a legal guardian,
forensic psychiatric arrangements, or if they do not give
informed consent.
Recruitment and randomisation
Eligible patients are informed about Sherpa, given the
written information, and subsequently referred to Sherpa
by their psychiatrists, nurse or social worker. A Sherpa
employee calls the patient to make an appointment for
inclusion and baseline interview. The assessor will interviewthe participants, but a Sherpa mentor will always attend
the interview in order to manage the randomisation
after the assessor has left and inform the participant
about allocation. When a participant is included in the
trial, central randomisation is performed when the Sherpa
mentor calls the Copenhagen Trial Unit and gives the
relevant participant information.
Randomisation is performed according to a computer-
generated allocation sequence with a varying block size
concealed from the investigators. The randomisation is
stratified by a) four diagnoses (F31: Bipolar affective
disorder; F30, F32-39: Affective disorders; F40: Phobic
anxiety disorders; or F41: Other anxiety disorders), and
b) two match groups (match group 2 or 3).
Blinding
It is not possible to blind the participants, the Sherpa
mentors, or career counsellors, practitioners and carers
who deliver the intervention. However, they are strongly
urged not to reveal the allocation to the rest of the research
team. The assessor and research team will be blinded to the
allocated intervention group throughout the entire trial
period. Should blinding be violated, a second assessor will
complete the follow-up interview. Furthermore, during
statistical analyses, the two intervention groups will be
coded as, for example, X and Y, and the code will not
be broken until the research team has drawn two con-
clusions; one assuming X is the intervention group and




Participants randomised to the Sherpa group will be offered
IPS-MA in addition to treatment-as-usual (see description
for the control group). A Danish protocol describing the
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sponding author. An English version is under construction.
The IPS-MA method is based on eight principles: 1) Sherpa
is the patient’s advocate, not an authority or a healthcare
provider; 2) the process is led by the individual’s goals
and focus is on patient resources; 3) assistance is flex-
ible, without time limits, and responsive to the needs
of the patient; 4) the goal is competitive employment
or education, without pre-vocational training; 5) the
belief is that returning to work is possible despite a
mental illness, but therapeutic recommendations in terms
of postponement are acknowledged; 6) liaison with health-
care and social workers ensures a coordinated service; 7) a
meaningful and realistic career plan will be developed and
evaluated continuously after job start; and 8) Sherpa is an
interdisciplinary team, which will be reflected in the assist-
ance of each individual.
Five basic services comprise IPS-MA:
1) Individualised mentor support based on psychiatric
knowledge. Sherpa mentors all have a background as
professionals in mental health services. In
cooperation with the participant, the Sherpa mentor
helps develop a plan of action in which resources
and problems in social life as well as working life are
clarified. The Sherpa mentor supports the participant
in how to structure and manage everyday life, renew
contact with friends and/or family, prepare important
meetings and live a healthy everyday life with the
disorder. The Sherpa mentors very often act as lay
representatives for the participants at meetings at the
local job centres or municipalities.
2) Coordination of services provided by Sherpa or
external providers. Through their professional skills,
Sherpa mentors help avoid lack of coordination and
unnecessary waiting time and make sure that all
available services are provided. Sherpa mentors have
an assertive approach to mental health carers and
social workers and thereby ensure that relevant
information is distributed between services.
3) Career counselling. Professional career counsellors
support participants in creating a realistic match
between their competences and the demands of the
job market. Participants will be given advice on how
to write a curriculum vitae and job applications, on
job seeking strategies, and help in practicing job
interviews and negotiating employment contracts.
4) Impartial help to clarify private economy is offered
by a consultancy firm, the Settlement [34], run by
volunteers. The firm consists of two employees and
a group of volunteers with professional backgrounds
in economics, law and social counselling.
5) Contact with employers to help participants obtain
jobs, and keep them.Participants are provided with a Sherpa mentor who
will be their mentor throughout the entire intervention
period. The search for job or education will commence
as soon as possible. Mentor support will continue for as
long as needed after employment or education is started.
During the first 6 months, the participant and mentor
most often meet once a week for 1 to 1.5 hours on average.
After 6 months the number of contacts varies and can be
by telephone or email. The number and duration of con-
tacts depend on the needs of the participant. Each mentor
has a maximum caseload of 20 participants, half of which
have been in Sherpa for more than 6 months.
Sherpa team
The Sherpa team is an interdisciplinary team, consisting
of six mentors and two career counsellors. Sherpa mentors
all have solid experience as health professionals in mental
health services and include one nurse, two social workers
and three occupational therapists. Career counsellors
have worked as career counsellors, or with recruitment
or human resources in the private business sector. Sherpa
mentors and career counsellors work closely together and
share offices.
Training and supervision
Newly appointed Sherpa mentors will have a 1-week
introduction to working routines, and will attend a 2-day
workshop introducing the IPS-MA method. Mentors with
experience in the method will conduct the introduction.
Team members are furthermore obliged to participate in
annual refresher courses.
Team members will have monthly supervision provided
by a trained psychologist.
The control group
Participants randomised to the control group will receive
‘treatment-as-usual’ as offered by the job centres in
Denmark [35]. Services vary according to match group and
the participant’s possibilities for social support. Participants
receiving sickness benefits must attend their first meeting
in the job centre within 8 weeks of sickness leave. Match
group 2 participants attend follow-up interviews every 4
weeks, whereas match group 3 participants attend follow-
up interviews every 3 months. Participants on social secur-
ity will attend job-seeking interviews every 3 months.
Participants under the age of 30 have the right and
obligation to participate in pre-vocational training
after no more than 13 weeks of unemployment. Pre-
vocational training has to last for at least 6 months.
Young participants must not be without some sort of
pre-vocational training for more than 4 weeks. Partici-
pants over the age of 30 have the right and obligation
to participate in pre-vocational training after no more
than 9 months of unemployment.
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certain pre-vocational training services: company internship
programmes in public or private companies as well as in
sheltered workshops, wage subsidy jobs, skill development
and guidance, and mentor support (often offered by a
colleague who helps the participant adapt to the new
workplace regarding norms and social competences).
Participants receiving sickness benefits can be provided
with gradual return to employment, assistive tools, a per-
sonal assistant or reimbursement of sickness benefits to the
employer from the first day of sickness leave [35].
Participant withdrawal
Participants can choose to withdraw from the trial at
any time during the intervention period, without it having
any consequences for the treatment they will receive, but
they will politely be reminded of the importance of their
participation. Participants who choose to withdraw from
the trial are asked to specify which aspects of the trial they
withdraw from: participation in the experimental inter-
vention, participation in the follow-up interviews, use of
data collected at central registers, or complete withdrawal
including use of already collected data.
Fidelity
To ensure that the services provided by Sherpa are in
concordance with the IPS-MA method, an independ-
ent investigator will monitor fidelity to the IPS-MA
method twice during the first year of the intervention,
and subsequently once every year. Fidelity will be mon-
itored using the IPS-MA Fidelity Scale (unpublished,
available through corresponding author) by interviewing
participants, mentors, and career counsellors, observ-
ing team-meetings and meetings between mentor and
participant, as well as examining the individual plans
of action and the data management systems used. The
IPS-MA Fidelity Scale was developed based on the IPS
Fidelity Scale [36]. Core elements important to the IPS-MA
method investigated are: caseload, mentors’ and career
counsellors’ roles, interdisciplinary team with group
supervision, individualised mentor support, development
and evaluation of individual plans of action, coordination
of services, providing career and economic counselling,
focus on rapid search for ordinary employment or educa-
tion, no time limitations, and individualised support for
the participants and their employers, community-based
services, assertive engagement and outreach.
Assessments
Participants will be interviewed and asked to fill in
questionnaires at baseline and at follow-up after 12 and24 months. At baseline, socio-demographic information
on education, income base, marital status, number of
children and somatic disease will be collected.
To confirm the diagnosis, the Mini International
Neuropsychiatric Interview (MINI) [37] is used at baseline.
Baseline interviews will always be face-to-face, most
often in the participants’ home. Participants will fill in
questionnaires at home.Outcomes
The primary outcome is competitive employment (in-
cluding being on rehabilitation benefits, flexible jobs,
and wage-subsidised jobs) or education at 24 months.
Information about employment and education will be
extracted from the DREAM database [38]. The database
is administered by The National Labour Market Author-
ity and contains information on employment, sickness
leave, and education eligible to state education grant,
pre-vocational training, disability pension, social secur-
ity, and sickness benefits.
Secondary outcomes are: 1) number of days of com-
petitive employment or education; 2) level of symptoms
assessed by the Hamilton Depression Scale (HAM-D6)
[39,40]; 3) level of symptoms assessed by the Hamilton
Anxiety Scale (HAM-A6) [39,41]; 4) level of functioning
assessed by The Global Assessment of Functioning (GAF)
[39,42,43]; and 5) level of health-related quality of life by
The WHO-Five Well-being Index(WHO-5) [39]. Secondary
outcomes are assessed after 12 and 24 months.
Exploratory outcomes are: competitive employment
(including being on rehabilitation benefits, flexible jobs
and wage subsidy jobs) or education at 12 months, re-
assignment from Match group 2 or 3 to Match group 1,
attending company internship programs in public or pri-
vate companies as well as in sheltered workshops, and
information extracted from the DREAM database.
Manic symptoms are assessed by the Bech-Rafaelsen
Mania Scale (MAS) [39,44]. Social performance regard-
ing four domains (socially useful activities, personal and
social relationships, self-care and disturbing and aggres-
sive behaviour) is assessed by The Personal and Social
Performance (PSP) [45,46]. The Sheehan Disability Scale
[47] measures functional level regarding social relation-
ships, work, spare time and family. Health-related qual-
ity of life in terms of psychological well-being is assessed
by the WHO-5 [39,48] and empowerment by the Em-
powerment Scale [49]. The Changes Questionnaire [50]
will be used to assess how motivated participants are
as to seeking employment or education. The Client
Satisfaction Questionnaire [51] assesses satisfaction with
treatment and the EQ-5D (EuroQol) [52] assesses
health-related quality of life. The latter of the two will be
used in a future health-related cost-benefit analysis. All
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are validated scales [37,39-47,49-52].
Register-based information
Information on vital status, use of mental health ser-
vices, both as in- and outpatient, number of days of ad-
mission, sickness absence and use of social benefits will
be gathered from the DREAM database or the Danish
Psychiatric Case Register (DPCR) [53]. DPCR is the
patient-registry system used by the mental health ser-
vices in Denmark; it contains information on all hospital
admissions, number and duration, outpatient contacts
and deaths.
An overview of all data collected and the source of
collection is shown in Table 1.Table 1 Data collection at baseline and follow-up
Source of collection Assessment
Interview Hamilton Depression Scale (HAM-D6)
Hamilton Anxiety Scale (HAM-A6)
Bech-Rafaelsen Mania Scale (MAS)
Personal and Social Perfomance scale (PSP)
Global Assessment of Functioning (GAF)
Suicidal ideation
Self report Sheehan Disability Scale (SDS)
Quality of life (WHO-5)
Empowerment Scale
Changes Questionnaire
Client Satisfaction Questionnaire (CSQ)
Health-related quality of life EQ-5D (EuroQol)
Hospital records Number of hospital admissions
Length of hospital admissions




Dream Labour market affiliation
Dream/interview Civil status




DPCR Use of mental health service
Dream Number of sick days
Dream Use of social benefits
Self report Treatment and use of other service from the social
Self report Service provided by Sherpa
DPCR, The Danish Psychiatric Case Register.All data will be handled in accordance with the Danish
Data Protection Agency.
Training and inter-rater reliability
Three assessors conduct the interviews: Britt Reuter
Morthorst (BM), Marie Lønberg Hansen (MLH) and
LH. BM and LH have a masters in health science, and
MLH in public health science. BM has 15 years experi-
ence as a nurse in mental health, and is an experienced
assessor. Assessors have all received the necessary train-
ing in the relevant instruments. All assessors have par-
ticipated in joint ratings for HAM-D and HAM-A with
PB. Regarding the MINI, MAS, PSP and GAF, at least
seven joint ratings have been conducted in order to
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x
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class coefficient was used [54]. The level of significance
was a coefficient of 0.70 or higher.
LH has participated in joint HAM-D6 and HAM-A6
rating sessions with PB. In total, 28 joint sessions be-
tween PB and LH were evaluated and for HAM-D6 the
intra-class coefficient was 0.81 (P < 0.001). Together LH
and BM have seen seven patients in joint training
sessions; intra-class correlations were: PSP = 0.92, GAF-
Functioning = 0.84, GAF-Symptoms = 0.75.
Power and sample size
We have been unable to find data on how many people
actually return to employment or education with trad-
itional pre-vocational training after anxiety or an
affective disorder in either the Danish or the national lit-
erature. Therefore, we have leaned towards the findings
in OPUS, a programme in which young people with
schizophrenia receive early intensive treatment for 24
months. In OPUS it was found that 40% returned to em-
ployment or education versus 32% in the control group
(Merete Nordentoft, personal communication). Based on
this knowledge, we conservatively estimate that 30% will
regain employment or education following traditional
pre-vocational training.
Across a broad range of studies of severe mental ill-
ness and IPS versus traditional pre-vocational training,
studies show that approximately 50% more of the partic-
ipants in the IPS groups regain employment compared
to the control groups [15]. We therefore expect to find
that 50% more of the participants in the Sherpa group
compared to the control group will regain employment
or education, and have estimated the true difference in
the experimental and control group to be 15%-points;
hence, 45% of the participants in the Sherpa group will
regain employment. To be able to reject the null hypoth-
esis that the proportion of participants who regain em-
ployment or education in the experimental and control
group is equal with a probability (power) of 80%, 162
participants will be required in each group (total 324).
The Type I error probability associated with the test ofTable 2 Power calculations for secondary outcomes, calculate
Measure Mean difference Standard de
of the poole
No of days of competitive employment
of education at 12 months





GAF, Global Assessment of Functioning; HAM-A6, Hamilton Anxiety Scale; HAM-D6,this null hypothesis is 5%. We also estimated the sample
size using a power of 90%. This resulted in a total of 434
participants (2 × 217). We therefore plan to recruit a
minimum of 324 participants and, in order to reduce the
risk of type II error, we will aim to recruit up to 434 par-
ticipants, if possible, in the 2-year recruitment period.
Power and sample size calculations have been made
using the PS Power and Sample Size Calculations pro-
gram version 3.0.14 [55,56].
The power for the secondary outcomes has been esti-
mated based on a number of 162 participants in each
group (Table 2). Since it has not been possible to find
studies or trials similar to our trial regarding patient group
or method, expected effect size concerning number of
days in employment or education has been conservatively
estimated. The studies found [1,9,19,21,22,57-59] did not
find any difference between groups after 12 months con-
sidering GAF-F, WHO-5, HAM-D6 or HAM-A6. If we
find a difference between groups, we want it to be clinic-
ally relevant; therefore, the effect sizes equals the clinically
relevant difference.
Statistical analyses
Data analyses will be based on the intention-to-treat
principle, which means that data will be included in the
group to which the participant was randomised, regardless
of intervention received. Data will be analysed using the
IBM SPSS Statistics version 20 for Windows.
To assess homogeneity of the two groups at baseline,
demographic data such as age, gender, marital status,
education level, support (social benefits, social security
and so forth), diagnosis and Match group at baseline
will be presented.
Dichotomous outcomes will be analysed using logistic
regression. For primary and secondary outcomes, an
unadjusted analysis of the effect of the Sherpa method
as an add-on to treatment-as-usual versus exclusively
treatment-as-usual will be carried out, as well as an analysis
adjusted for stratification variables (diagnosis and Match
group). Multiple multivariate imputations will be used






5% Kin W 2008 [21], Burns 2007 [14] 95%
5% Hoffmann 2011 [19], Howard 2010 [58] 85%
5% Latimer 2006 [22], Burns 2009 [14] 99%
5% Wang 2007 [10], Lexis 2011 [9],
Brouwers 2006 [1], Van Oostrom 2010 [59]
99%
5% Wang 2007 [10], Lexis 2011 [9],
Brouwers 2006 [1], Van Oostrom 2010 [59]
99%
Hamilton Depression Scale; WHO-5, WHO-Five Well-being Index.
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with repeated measurements. This model is based on the
assumption that data are missing at random or missing
completely at random [60].Feasibility
In 2010, 11,712 inpatient visits were registered in the
Mental Health Care Centres of the Capital Region of
Denmark, not including emergency wards [61]. During the
same period of time there were 4,538 first-time psychiatric
emergency ward visits in the Capital Region of Denmark
[61]. Based on these figures we find it realistic to include a
minimum of 324 participants from 1 October 2011 until
31 December 2013.
Each mentor has a maximum caseload of 20 participants
per year; six mentors are currently engaged in Sherpa.
Thus it is also realistic regarding the capacity of Sherpa
mentors to include and complete the intervention for
162 participants in 3 years.Ethical considerations
All participants in this trial, randomised to experimental
as well as control group, are offered treatment according
to best practice. The trial will follow international ethical
guidelines of informed consent in clinical trials. Partici-
pants will receive written and verbal information about
the trial so as to be able to give an informed consent.
Consent has to be given verbally and in writing. Partici-
pation is voluntary, and participants can withdraw their
consent at any time during the trial without it having
any consequences for their treatment. Previous trials
have not found any risks or adverse reactions to the sup-
ported employment intervention [19,31,62,63]. If any of
the participants present suicidal ideations, the mentor
and assessor will make sure that they can be distracted
from these thoughts, have a crisis plan, are not alone
after the interview and, if in doubt of any of the above,
they will offer to follow the participant to the psychiatric
emergency ward.
The trial protocol was submitted to the Regional
Ethics Committees of the Capital Region for review
(journal no: H-2-2011-FSP20). The committee assessed the
protocol to be exempt from formal approval, since it is not
a biomedical trial. The trial has been reported to the Danish
Data Protection Agency (RHP journal no: 2007-58-0015,
local journal no: RHP-2011-20) and has been registered
at http://www.clinicaltrials.gov identifier: NCT01721824.Trial status
The trial is on-going; 290 participants have been rando-
mised, and recruitment continues until 31 January 2014.Discussion
The IPS-MA method is based on a 1-year pilot study
and the evidence supporting IPS in other countries. To
our knowledge this is the first trial investigating the effect
of a supported employment intervention when provided
to people with a recently diagnosed affective disorder
or anxiety disorder, an area with only sparse knowledge
about effective interventions. A strength of the study is
the centralised computer-based randomisation which en-
sures an adequate generation of the allocation sequence
and adequate allocation concealment. The use of blinded
outcome assessors for the primary outcome and the fact
that it is a register-based outcome as well as the use of
intention-to-treat analysis decreases the risk of biased effect
estimates. The trial is registered at http://www.clinicaltrials.
gov, which helps preventing selective and incomplete out-
come reporting. The primary outcome is register-based,
which ensures almost complete follow-up due to the
comprehensiveness of Danish registers.
The fact that we monitor fidelity to the IPS-MA method
on a yearly basis is another strength of this trial. We do
so to ensure that mentors and career counsellors are
true to the method.
A limitation to this trial is that we are not able to blind
participants, mentors or carers. Some might argue that
it is difficult to sustain the blinding of the assessor dur-
ing follow-up, and this is certainly a risk of bias. Should
blinding be violated, a second assessor will complete the
follow-up interview.
Even though participants are recruited from mental
health centres throughout the Capital Region of Denmark,
and should be fairly representative of the population in the
region, we may have a reduced external validity. As it is the
staff at the mental health centres that identify eligible par-
ticipants, not everybody with an affective disorder or anx-
iety disorder eligible might have been asked to participate;
patients are not systematically screened for eligibility.
Due to differences in labour markets and well-fare
systems, results may not be directly generalisable to
other countries.
Impact of the results
The results of this trial will add to the limited knowledge
regarding vocational rehabilitation for people with recently
diagnosed anxiety or affective disorders. If potential positive
results can be confirmed in other trials, the IPS-MA
method can be implemented at the job centres nationwide,
and would probably prevent a large number of disability
pensions and long-term sickness absences with major bene-
fits to society and patients.
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